Evaluation of the Irradiated Volume of the Heart and Cardiac Substructures After Left Breast Radiotherapy.

ARETI GKANTAIFI , CHRISTODOULOS PAPADOPOULOS , DESPOINA SPYROPOULOU , MARIA TOUMPOURLEKA
Anticancer Research 40 ( 5) 3003 -3009

1
2020
Comparative E-Cadherin Digital Expression Analysis in HPV and non-HPV Related Squamous Cell Carcinoma of the Oral Cavity.

ARISTEIDIS CHRYSOVERGIS , VASILEIOS PAPANIKOLAOU , NICHOLAS MASTRONIKOLIS , DESPOINA SPYROPOULOU
Anticancer Research 41 ( 1) 163 -167

2021
Breast Radiotherapy and Early Adverse Cardiac Effects. The Role of Serum Biomarkers and Strain Echocardiography.

ARETI GKANTAIFI , CHRISTODOULOS PAPADOPOULOS , DESPOINA SPYROPOULOU , MARIA TOUMPOURLEKA
Anticancer Research 39 ( 4) 1667 -1673

8
2019
CLINICAL IMPLEMENTATION OF PET/CT IMAGING IN RADIOTHERAPY TREATMENT PLANNING

A Vasilou , S Papatheodorou , N Papathanasiou , D Spyropoulou
Physica Medica: European Journal of Medical Physics 104 S23 -S23

2022
Stereotactic radiotherapy for brain lesions: Analysis of treatment outcomes and toxicity from a single center

V Vassiliou , Ch Christopoulos , D Spyropoulou , M Pomoni
RADIOTHERAPY AND ONCOLOGY 81 S491 -S491

2006
Does age influence the rate and severity of radiotherapy side effects in patients with prostate cancer?

C Christopoulos , V Vassiliou , M Puglisi , D Spyropoulou
RADIOTHERAPY AND ONCOLOGY 81 S320 -S320

2006
Impact of K-Ras Over-expression in Laryngeal Squamous Cell Carcinoma.

Dimitrios Peschos , Nicholas Mastronikolis , Vasileios Ragos , Evangelos Tsiambas
in Vivo 35 ( 3) 1611 -1615

2021
Radiotherapy and Renal Cell Carcinoma: A Continuing Saga.

Dimitrios Kardamakis , Haralabos Kalofonos , Angelos Koutras , Despoina Spyropoulou
in Vivo 35 ( 3) 1365 -1377

2021
C-Fos Digital Expression Analysis in Human PapillomavirusRelated Oral Squamous Cell Carcinoma

Dimitrios Peschos , Nicholas Mastronikolis , Chara Stavraka , Vasileios Ragos
Asian Pacific Journal of Cancer Biology 6 ( 2) 117 -121

2021
Primary extramammary invasive Paget’s vulvar disease: what is the standard, what are the challenges and what is the future for radiotherapy?

Maria Tolia , Nikolaos Tsoukalas , Chrisostomos Sofoudis , Constantinos Giaginis
BMC Cancer 16 ( 1) 563 -563

15
2016
Exceptional response to nivolumab of a heavily pre-treated patient with metastatic renal-cell cancer: from a case report to molecular investigation and future perspectives.

Foteinos-Ioannis D. Dimitrakopoulos , Eleni Kourea , George Nasioulas , Eirini Papadopoulou
Therapeutic Advances in Medical Oncology 12 1758835920946152

2020
Secretory Phospholipase A2 Digital Expression Analysis in Colon Adenocarcinoma

Evangelos Falidas , Eirini Kitsiouli , Despoina Spyropoulou , Evangelos Tsiambas
in vivo 36 ( 2) 738 -742

2022
P53 suppressor gene tissue microarray-based protein expression analysis in meningiomas

Dimitrios Roukas , Anastasios Kouzoupis , Despoina Spyropoulou , George Papanastasiou
in vivo 36 ( 5) 2205 -2210

1
2022
Caspase 8 Expression Patterns in Meningiomas: A Tissue Microarray Digital Image Analysis

Dimitrios Roukas , Anastasios Kouzoupis , Despoina Spyropoulou , Evangelos Tsiambas
Cureus 14 ( 6)

2022
Impact of caspase 3 expression in meningiomas based on tissue microarray analysis

Dimitrios Roukas , Evangelos Tsiambas , Maria Adamopoulou , Despoina Spyropoulou

MicroRNA signatures landscape in renal cell carcinoma-related epithelial to mesenchymal transition

Grigorios Theodoropoulos , Evangelos Tsiambas , Paraskevi Tziakou , Despoina Spyropoulou

Caspases–related apoptosis in meningiomas

Dimitrios Roukas , Stylianos Mastronikolis , Evangelos Tsiambas , Despoina Spyropoulou

An exploratory study of radiation dermatitis in breast cancer patients

Eleftheria Alexopoulou , Theodora Katsila , Maria Tolia , Nikolaos Tsoukalas
Anticancer research 38 ( 3) 1615 -1622

15
2018
Immunohistochemistry coupled to pathway analysis delineates radiation dermatitis in breast cancer patients

Theodora Katsila , Eleftheria Alexopoulou , Michael Leontsinidis , Vassileios Kouloulias
STRAHLENTHERAPIE UND ONKOLOGIE 193 ( 10) 871 -871

2017